Lehrieder, Dominik http://orcid.org/0000-0002-2339-8598
Müller, Hans-Peter
Kassubek, Jan
Hecht, Nils
Thomalla, Götz
Michalski, Dominik
Gattringer, Thomas
Wartenberg, Katja E.
Schultze-Amberger, Jörg
Huttner, Hagen
Kuramatsu, Joji B.
Wunderlich, Silke
Steiner, Hans-Herbert
Weissenborn, Karin
Heck, Suzette
Günther, Albrecht
Schneider, Hauke
Poli, Sven
Dohmen, Christian
Woitzik, Johannes
Jüttler, Eric
Neugebauer, Hermann
,
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 1 April 2023
Revised: 2 May 2023
Accepted: 3 May 2023
First Online: 10 May 2023
Declarations
:
: D. Lehrieder, H.P. Müller, J. Kassubek, G. Thomalla, D. Michalski, T. Gattringer, K.E. Wartenberg, J. Schultze-Amberger, H. Huttner, J.B. Kuramatsu, S. Wunderlich, H.H. Steiner, K. Weissenborn, S. Heck, H. Schneider, C. Dohmen, J. Woitzik and H. Neugebauer report no disclosures relevant to the manuscript; N. Hecht is Berlin Institute of Health Clinical Fellow, funded by Stiftung Charité; S. Poli is coordinating investigator of Automatic PredICtion of Edema after Stroke (APICES) study (ClinicalTrials.gov unique identifier: NCT04057690); A. Günther reports honoria from Pfizer, Bristol-Myers-Squibb, Boeringer Ingelheim, Daiichi Sankyo, Occlutech, Ipsen Pharma and Merz outside the submitted work; E. Jüttler reports honoria from Pfizer, Bristol-Myers-Squibb, Boehringer Ingelheim, Daiichi Sankyo and Stryker outside the submitted work. He was Principle Investigator of DESTINY and DESTINY II, Co-Investigator of the pooled analyses of randomized hemicraniectomy trials and Co-author of guidelines on intracranial pressure treatment and treatment of space-occupying brain infarction.
: The trial was registered in the German Registry for Clinical Studies (DRKS00000624). The ethics committee of the Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin (EA4/108/09) and the local ethics committees of all participating centers approved this registry. Written informed consent was obtained from all patients or legal representatives.